🎧 New: AI-Generated Podcasts Turn your study notes into engaging audio conversations. Learn more

ESC Guideline on Non-Invasive HTM
28 Questions
1 Views

ESC Guideline on Non-Invasive HTM

Created by
@BeneficiarySetting

Podcast Beta

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What is the recommended treatment for patients with low cardiac output and evidence of organ hypoperfusion as a bridge to MCS or heart transplantation?

  • Diuretics and antiarrhythmic medications
  • Continuous inotropes and/or vasopressors (correct)
  • Anticoagulants and beta-blockers
  • Dietary changes and lifestyle modifications
  • What is the recommended timeframe for the first follow-up visit after discharge for patients hospitalized for heart failure?

  • Within 4-6 weeks
  • Within 1-2 weeks (correct)
  • Within 2-4 weeks
  • Within 1 month
  • For patients with heart failure and atrial fibrillation, what is the recommended CHA2DS2-VASc score threshold for considering long-term treatment with an oral anticoagulant for stroke prevention?

  • CHA2DS2-VASc score of 2 in men or 3 in women
  • CHA2DS2-VASc score of 0 in men or 1 in women
  • CHA2DS2-VASc score of 1 in men or 2 in women (correct)
  • CHA2DS2-VASc score of 3 in men or 4 in women
  • For patients with heart failure and coronary artery disease, what is the recommended revascularization strategy?

    <p>CABG should be considered as the first-choice revascularization strategy, especially in patients with diabetes and multivessel disease</p> Signup and view all the answers

    For LVAD candidates with heart failure who need coronary revascularization, what is the recommended approach?

    <p>Revascularization should be avoided, if possible</p> Signup and view all the answers

    For patients with heart failure, reduced ejection fraction, and coronary artery disease, when may coronary revascularization be considered?

    <p>Coronary revascularization may be considered to improve outcomes, after careful evaluation of the individual risk-benefit ratio</p> Signup and view all the answers

    What percentage of patients in the PARAGON-HF study were on beta-blockers at baseline?

    <p>80%</p> Signup and view all the answers

    Which drug has the FDA endorsed for use in patients with an LVEF 'less than normal'?

    <p>Sacubitril/valsartan</p> Signup and view all the answers

    What percentage of patients in the PARAGON-HF study were on ACE-I/ARBs at baseline?

    <p>More than 86%</p> Signup and view all the answers

    What is the key reason for endorsing the use of sacubitril/valsartan and spironolactone?

    <p>Reduction in HF hospitalizations</p> Signup and view all the answers

    Which guideline acknowledges that treatment options for HFpEF are being revised?

    <p>The Task Force guideline</p> Signup and view all the answers

    Which of the following SGLT2 inhibitors is recommended for patients with type 2 diabetes and heart failure with reduced ejection fraction (HFrEF) to reduce hospitalizations for heart failure and cardiovascular death?

    <p>Dapagliflozin, empagliflozin, and sotagliflozin</p> Signup and view all the answers

    Which of the following statements is true regarding the DPP-4 inhibitor saxagliptin?

    <p>It is not recommended for patients with heart failure.</p> Signup and view all the answers

    Which of the following tests is recommended for periodically screening patients with heart failure for anemia and iron deficiency?

    <p>Complete blood count (CBC), serum ferritin concentration, and transferrin saturation (TSAT)</p> Signup and view all the answers

    Which of the following SGLT2 inhibitors is recommended for patients with type 2 diabetes at risk of cardiovascular events to reduce hospitalizations for heart failure, major cardiovascular events, end-stage renal dysfunction, and cardiovascular death?

    <p>Canagliflozin, dapagliflozin, empagliflozin, ertugliflozin, and sotagliflozin</p> Signup and view all the answers

    Which of the following statements is true regarding the management of patients with heart failure and diabetes?

    <p>SGLT2 inhibitors are recommended for patients with type 2 diabetes at risk of cardiovascular events and for those with heart failure with reduced ejection fraction.</p> Signup and view all the answers

    What is the purpose of the ESC Guideline mentioned in the text?

    <p>To help health professionals manage people with heart failure according to the best available evidence</p> Signup and view all the answers

    What is the recommended therapy for patients being considered for long-term MCS?

    <p>Good compliance, appropriate capacity for device handling, and psychosocial support</p> Signup and view all the answers

    What is the focus of the tabular recommendations for heart failure with reduced ejection fraction (HFrEF)?

    <p>Mortality and morbidity outcomes</p> Signup and view all the answers

    What is the purpose of the web appendices mentioned in the text?

    <p>To provide detailed summaries of the trials underpinning the recommendations</p> Signup and view all the answers

    What is the current status of heart failure?

    <p>It is now both preventable and treatable</p> Signup and view all the answers

    What is the focus of the therapy recommendations mentioned in the text?

    <p>Treatment effect supported by class and level of evidence</p> Signup and view all the answers

    Which type of heart failure is characterized by an ejection fraction greater than 50%?

    <p>Heart failure with preserved ejection fraction (HFpEF)</p> Signup and view all the answers

    Which of the following is not a commonly used index for the diagnosis of HFpEF?

    <p>Left atrial volume index</p> Signup and view all the answers

    What is the sensitivity and specificity of using tricuspid regurgitation velocity at rest for the presence of HFpEF?

    <p>Sensitivity 54%, specificity 85%</p> Signup and view all the answers

    Which of the following is not a recommended treatment for patients with a history of overtly reduced LVEF who have recovered to an LVEF greater than 50%?

    <p>Discontinuation of all heart failure medications</p> Signup and view all the answers

    Which of the following is not a condition mentioned in the text that warrants consideration of intravenous iron supplementation with ferric carboxymaltose?

    <p>Patients with HFrEF</p> Signup and view all the answers

    What is the purpose of the note stating 'The greater the number of abnormalities present, the higher the likelihood of HFpEF'?

    <p>To suggest that the presence of multiple abnormalities increases the likelihood of HFpEF</p> Signup and view all the answers

    More Quizzes Like This

    ESC ACS 2023
    13 questions

    ESC ACS 2023

    ImmaculateInspiration avatar
    ImmaculateInspiration
    Levels of Evidence in Medical Research
    10 questions
    Use Quizgecko on...
    Browser
    Browser